Last update 25 Nov 2024
CBP-1019
Last update 25 Nov 2024
Overview
Basic Info
Drug Type Small molecule-drug conjugates |
Synonyms Folate-TRPV6-peptide exatecan drug conjugate (Coherent), CBP 1019, CBP1019 |
Target |
Mechanism FOLR1 antagonists(Folate receptor alpha antagonists), TOP1 inhibitors(DNA topoisomerase I inhibitors), TRPV6 antagonists(Transient receptor potential cation channel subfamily V member antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Login to view timeline
Related
4
Clinical Trials associated with CBP-1019Phase Ib Study of CBP-1019 in Combination with FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
评价注射用CBP-1019在晚期胸部恶性肿瘤患者中安全性和耐受性、药代动力学及初步疗效的Ⅰ期临床研究
[Translation] A Phase I clinical study to evaluate the safety and tolerability, pharmacokinetics and preliminary efficacy of CBP-1019 for injection in patients with advanced thoracic malignancies
评价注射用CBP-1019在晚期恶性实体瘤患者中安全性和耐受性、药代动力学及初步疗效的非随机、开放、首次用于人体的国际多中心Ⅰ/Ⅱ期临床研究
[Translation] A non-randomized, open-label, first-in-human, international, multicenter Phase I/II clinical study to evaluate the safety and tolerability, pharmacokinetics, and preliminary efficacy of CBP-1019 for injection in patients with advanced malignant solid tumors
100 Clinical Results associated with CBP-1019
Login to view more data
100 Translational Medicine associated with CBP-1019
Login to view more data
100 Patents (Medical) associated with CBP-1019
Login to view more data
100 Deals associated with CBP-1019
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | US | 14 Mar 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | CN | 14 Mar 2023 | |
| Breast Cancer | Phase 2 | US | 14 Mar 2023 | |
| Breast Cancer | Phase 2 | CN | 14 Mar 2023 | |
| Colorectal Cancer | Phase 2 | US | 14 Mar 2023 | |
| Colorectal Cancer | Phase 2 | CN | 14 Mar 2023 | |
| Esophageal Carcinoma | Phase 2 | US | 14 Mar 2023 | |
| Esophageal Carcinoma | Phase 2 | CN | 14 Mar 2023 | |
| Lung Cancer | Phase 2 | US | 14 Mar 2023 | |
| Lung Cancer | Phase 2 | CN | 14 Mar 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free